Redmile Group LLC 13D and 13G filings for RAPT Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 8:02 pm Purchase |
2024-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
Redmile Group LLC | 13,932,449 9.900% |
10,155,602 (+268.89%) |
Filing |
| 2024-02-14 4:26 pm Purchase |
2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
Redmile Group LLC | 3,776,847 9.900% |
97,009 (+2.64%) |
Filing |
| 2023-02-14 4:21 pm Purchase |
2022-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
Redmile Group LLC | 3,679,838 9.900% |
480,475 (+15.02%) |
Filing |
| 2022-06-03 5:16 pm Purchase |
2022-05-24 | 13G | RAPT Therapeutics, Inc. RAPT |
Redmile Group LLC | 3,199,363 9.900% |
3,199,363 (New Position) |
Filing |